| OTLK YTD Return Table | ||||||||||||||||||||||||||||||
OTLK YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare OTLK YTD return (see YTD Return Meaning) versus benchmarks: YTD Return S&P YTD Return Dow YTD Return Nasdaq 100 YTD Return Russell 2000 YTD Return Gold YTD Return 10 Year Treasury YTD Return By Sector |
| OTLK Share Performance |
| OTLK YTD Return Chart | |||
Also see: OTLK Average Annual Return | |||
| About Outlook Therapeutics Inc |
| Outlook Therapeutics, Inc. is a biopharmaceutical company. Co. focuses on developing and commercializing ONS-5010 (LYTENAVA (bevacizumab-vikg)), an ophthalmic formulation of bevacizumab for use in retinal indications. Co.'s product candidate, ONS-5010, is developed to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO). Bevacizumab is a full-length, humanized anti-Vascular Endothelial Growth Factor (VEGF) recombinant monoclonal antibody (mAb), that inhibits VEGF and associated angiogenic activity. The OTLK YTD return is shown above.
The YTD Return on the OTLK YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether OTLK YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the OTLK YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| OTLK Current Stock Quote |
 Free OTLK Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Outlook Therapeutics (OTLK) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
OTRK YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!